Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2021

01-03-2021 | Septicemia | Case report

Antineoplastics

Toxic sepsis: case report

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
…
Literature
Aussedat G, et al. Pvag regimen (prednisone, vinblastine, doxorubicin, gemcitabine) used in real-life setting in first line therapy for elderly classical hodgkin lymphoma patients: A retrospectivestudy of lysa centers. Blood 136 (Suppl. 1): 11, 5 Nov 2020. Available from: URL: http://​doi.​org/​10.​1182/​blood-2020-138706 [abstract]
Metadata
Title
Antineoplastics
Toxic sepsis: case report
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-92615-6

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

Trametinib

Case report

Blinatumomab

Case report

Multiple drugs

Case report

Antineoplastics

Case report

Itraconazole

Case report

Bortezomib